Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRGX
1376
DELISTED
PRGX Global, Inc.
PRGX
| $7.83M | 0.01% |
1,665,199
+50,307
| +3% | +$180K |
|
|
VG
1377
DELISTED
Vonage Holdings Corporation
VG
| $7.82M | 0.01% |
+777,226
| New | +$6.97M |
|
1378
Graphic Packaging
GPK
$3.39B
| $7.8M | 0.01% |
557,618
-873,056
| -61% | -$11.7M |
|
|
ENZ
1379
DELISTED
Enzo Biochem, Inc.
ENZ
| $7.76M | 0.01% |
3,465,278
+153,300
| +5% | +$394K |
|
1380
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $7.74M | 0.01% |
71,800
-20,700
| -22% | -$2.22M |
|
1381
Green Dot
GDOT
$771M
| $7.73M | 0.01% |
+157,500
| New | +$5.33M |
|
1382
New Jersey Resources
NJR
$5.66B
| $7.73M | 0.01% |
236,621
-159,880
| -40% | -$5.3M |
|
1383
Fastly Inc
FSLY
$4.75B
| $7.72M | 0.01% |
+90,700
| New | +$3.57M |
|
1384
Forward Air
FWRD
$644M
| $7.72M | 0.01% |
154,939
+67,500
| +77% | +$3.31M |
|
1385
Ethan Allen Interiors
ETD
$579M
| $7.71M | 0.01% |
651,700
+111,800
| +21% | +$1.24M |
|
1386
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $7.7M | 0.01% |
82,600
+56,700
| +219% | +$5.19M |
|
|
GV
1387
DELISTED
Goldfield Corporation
GV
| $7.67M | 0.01% |
2,068,204
+176,129
| +9% | +$614K |
|
1388
Citi Trends
CTRN
$614M
| $7.62M | 0.01% |
376,825
-118,400
| -24% | -$1.55M |
|
1389
Kohl's
KSS
$2.22B
| $7.59M | 0.01% |
365,576
-2,462,363
| -87% | -$47.5M |
|
1390
Dynatrace
DT
$14.4B
| $7.59M | 0.01% |
186,900
+132,775
| +245% | +$4.37M |
|
|
OXFD
1391
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $7.58M | 0.01% |
582,700
+85,400
| +17% | +$1.03M |
|
1392
Spire
SR
$4.9B
| $7.56M | 0.01% |
115,100
-322,616
| -74% | -$23M |
|
|
CCRD
1393
DELISTED
CoreCard
CCRD
| $7.54M | 0.01% |
221,097
+40,700
| +23% | +$1.36M |
|
|
SVC
1394
Service Properties Trust
SVC
$1.06B
| $7.48M | 0.01% |
210,980
-11,260
| -5% | -$392K |
|
|
GHG
1395
GreenTree Hospitality
GHG
$113M
| $7.47M | 0.01% |
554,393
+120,700
| +28% | +$1.52M |
|
|
ZNH
1396
DELISTED
China Southern Airlines Company Limited
ZNH
| $7.44M | 0.01% |
337,000
-23,000
| -6% | -$521K |
|
1397
Autoliv
ALV
$8.97B
| $7.41M | 0.01% |
115,018
+21,082
| +22% | +$1.27M |
|
|
ABB
1398
DELISTED
ABB Ltd
ABB
| $7.39M | 0.01% |
327,700
-932,100
| -74% | -$17.9M |
|
|
BEST
1399
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $7.37M | 0.01% |
86,100
+40,525
| +89% | +$4.16M |
|
1400
Pebblebrook Hotel Trust
PEB
$2.07B
| $7.36M | 0.01% |
539,095
-732,000
| -58% | -$9.07M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.